Skip to main content
Premium Trial:

Request an Annual Quote

Data as Far as the Eye Can See

All the sequencers at BGI generate so much data that the institute has to use FedEx to send disks of data to its collaborators, highlighting the data storage and management problems facing genomics research, says The New York Times. However, the article adds that the problem is also creating opportunities for bioinformaticians and bioinformatics companies. "We believe the field of bioinformatics for genetic analysis will be one of the biggest areas of disruptive innovation in life science tools over the next few years," wrote Goldman Sachs analyst Isaac Ro in a recent report. The Times adds that the situation will only worsen with the addition of RNA, protein, and metagenomic data, though some researchers are turning to computing solutions like relying on the cloud or a collaboration with Google.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.